Dr. Akhilesh Prajapati

About

Dr. Akhilesh Prajapati has earned his doctoral degree in Biochemistry with a specialization in Benign Prostate Hyperplasia, an endocrine and reproductive pathophysiological manifestation prevalent in males from the department of biochemistry, The Maharaja Sayajirao University of Baroda. The astute outcome of his Ph.D. research was to establish an economic and novel BPH rodent model that evidently helped in exploring the hidden myths of BPH pathogenesis and Prostate Cancer.
Dr. Prajapati’s thrust area of research is to try to understand mechanisms underlying oncogenic development in breast and Prostate tissues facilitated by molecular and cellular crosstalk between cell types. Additionally, shed some light on the signaling pathways, cell surface receptors, and cancer stem cells involved in cancer development and progression. He has published several research papers in peer-reviewed international scientific journals in his repute and attended/ presented work at various national and International conferences, and symposiums. He has received many awards which include the prestigious INSA visiting scientist fellowship, and the Best Ph.D. Award by Gujarat Science academy, DBT- International travel award, best poster award, and nominated for Rayan international award, etc. He is also an active member of various national and international scientific committees and served as a reviewer of various renowned scientific journals.

Employment

• GSFC University Associate Professor/ Associate Dean R&D
  2017 - Present
• Maharaja Sayajirao University of Baroda Assistant Professor
  2014 - 2017

Education

• Gujarat National Law University Post Graduate Diploma in Biotechnology, Law and Policy
  2023 - 2023
• The Maharaja Sayajirao University of Baroda Ph.D/ Dr.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Deciphering the Role of Environmental Exposures in Androgen-Resistant Prostate Cancer an Insights from Multi-Omics and Toxicogenomics
  2025 DOI: 10.4018/979-8-3373-5796-6.ch004
  +Save
• New insights into prostate Cancer from the renin-angiotensin-aldosterone system.
  Cellular Signalling 2024 DOI: 10.1016/j.cellsig.2024.111442
  +Save
• Unveiling LGR5: Prostate cancer's hidden stem cell and treatment target
  Urologic Oncology: Seminars and Original Investigations 2024 DOI: 10.1016/j.urolonc.2024.10.001
  +Save
• Facile Green Synthesis of Iron Oxide Nanoparticles and Their Impact on Cytotoxicity, Antioxidative Properties and Bactericidal Activity
  Iranian Biomedical Journal 2024 DOI: 10.61186/ibj.4061
  +Save
• Hematopoiesis and Cancer stem cells: the seed and soil crosstalk
  Hematopoiesis: Biochemical, Cellular, Molecular, and Genomic Perspectives 2023
  +Save
• Cancer Cachexia and breast cancer stem cell signalling – A crosstalk of signalling molecules
  Cellular Signalling 2023 DOI: 10.1016/j.cellsig.2023.110847
  +Save
• Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure
  Journal of Trace Elements in Medicine and Biology 2020 DOI: 10.1016/j.jtemb.2020.126633
  +Save
• Analysis of AR, PSA (KLK) and ER-β genetic variants and Benign Prostate Hyperplasia (BPH) pathogenesis in Indian population
  Biomedical Research Journal 2016 DOI: 10.4103/2349-3666.240607
  +Save
• Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation
  Chemico-Biological Interactions 2015 DOI: 10.1016/j.cbi.2015.08.022
  +Save
• Cu(II) Complexes of Isoniazid Schiff Bases: DNA/BSA Binding and Cytotoxicity Studies on A549 Cell Line
  Advances in Chemistry 2014 DOI: 10.1155/2014/630575
  +Save